Abstract Endocannabinoids have been shown to play a complex role in the pathophysiology of a number of cardiovascular disorders. In…
Abstract Atherosclerosis is associated with vascular smooth muscle cell proliferation, chronic vascular inflammation, and leukocyte adhesion. In view of the…
Abstract The endocannabinoid system has been shown to be involved in various skin functions, such as melanogenesis and the maintenance…
Abstract Therapeutic drug monitoring of Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) is based on a complex procedure and is therefore not…
Abstract Simple Summary: Cannabidiol (CBD) is a phytocannabinoid from Cannabis sativa L. that exhibits no psychoactivity and, like the psychoactive…
Abstract Simple Summary: Recent research has suggested that the endocannabinoid system offers several pharmacotherapeutic targets for drug administration as new…
Abstract Drugs that target the endocannabinoid system are of interest as pharmacological options to combat cancer and to improve the…
Abstract Simple Summary: Cannabinoids have been shown to suppress tumour cell proliferation, tumour invasion, metastasis, angiogenesis, chemoresistance and epithelial-mesenchymal transition…
Abstract The administration of adipose tissue-derived mesenchymal stem cells (ADMSCs) represents a promising therapeutic option after myocardial ischemia or myocardial…
Abstract Cannabidiol (CBD), a non-psychoactive cannabinoid, has been reported to mediate antioxidant, anti-inflammatory, and anti-angiogenic effects in endothelial cells. This…